Rulide en es it fr

Rulide Brand names, Rulide Analogs

Rulide Brand Names Mixture

  • No information avaliable

Rulide Chemical_Formula


Rulide RX_link

No information avaliable

Rulide fda sheet

Rulide msds (material safety sheet)

Rulide Synthesis Reference

No information avaliable

Rulide Molecular Weight

906.628 g/mol

Rulide Melting Point

257 to 267 oC (decomposes with the evolution of gas)

Rulide H2O Solubility

No information avaliable

Rulide State


Rulide LogP

No information avaliable

Rulide Dosage Forms

Liquid (for injection)

Rulide Indication

For use as an anesthesia adjunct to induce skeletal muscle relaxation and to reduce the intensity of muscle contractions in convulsive therapy.

Rulide Pharmacology

Metocurine iodide is a benzylisoquinolinium competitive nondepolarizing neuromuscular blocking agent. Metocurine iodide has a moderate risk of inducing histamine release and has some ganglion blocking activity. Metocurine iodide can be used most advantageously if muscle twitch response to peripheral nerve stimulation is monitored to assess degree of muscle relaxation. As with other nondepolarizing neuromuscular blockers, the time to onset of paralysis decreases and the duration of maximum effect increases with increasing doses of metocurine iodide. Repeated administration of maintenance doses of metocurine iodide has no cumulative effect on the duration of neuromuscular block if recovery is allowed to begin prior to repeat dosing. Moreover, the time needed to recover from repeat doses does not change with additional doses. Repeat doses can therefore be administered at relatively regular intervals with predictable results.

Rulide Absorption

No information avaliable

Rulide side effects and Toxicity

Excessive doses can be expected to produce enhanced pharmacological effects. Overdosage may increase the risk of histamine release and cardiovascular effects, especially hypotension.

Rulide Patient Information

No information avaliable

Rulide Organisms Affected

Humans and other mammals